Home

Rassicurare Validazione pesante cappellini and thalassemia treatments haematologica 2017 oggi balcone spazzato dal vento

Replacing the suppressed hormone: toward a better treatment for iron  overload in β-thalassemia major? | Haematologica
Replacing the suppressed hormone: toward a better treatment for iron overload in β-thalassemia major? | Haematologica

Beta Thalassemia: New Therapeutic Options Beyond Transfusion and Iron  Chelation | SpringerLink
Beta Thalassemia: New Therapeutic Options Beyond Transfusion and Iron Chelation | SpringerLink

Β-Thalassemias | NEJM
Β-Thalassemias | NEJM

Frontiers | The Future of Gene Therapy for Transfusion-Dependent Beta- Thalassemia: The Power of the Lentiviral Vector for Genetically Modified  Hematopoietic Stem Cells
Frontiers | The Future of Gene Therapy for Transfusion-Dependent Beta- Thalassemia: The Power of the Lentiviral Vector for Genetically Modified Hematopoietic Stem Cells

Gene Therapy For Beta-Thalassemia: Updated Perspectives | TACG
Gene Therapy For Beta-Thalassemia: Updated Perspectives | TACG

A paradigm shift on beta-thalassaemia treatment: How will we manage this  old disease with new therapies? - ScienceDirect
A paradigm shift on beta-thalassaemia treatment: How will we manage this old disease with new therapies? - ScienceDirect

IJMS | Free Full-Text | Non-Transfusion-Dependent Thalassemia: An Update on  Complications and Management
IJMS | Free Full-Text | Non-Transfusion-Dependent Thalassemia: An Update on Complications and Management

Cure for thalassemia major – from allogeneic hematopoietic stem cell  transplantation to gene therapy | Haematologica
Cure for thalassemia major – from allogeneic hematopoietic stem cell transplantation to gene therapy | Haematologica

Pathophysiology and treatment of patients with... | F1000Research
Pathophysiology and treatment of patients with... | F1000Research

Cure for thalassemia major – from allogeneic hematopoietic stem cell  transplantation to gene therapy | Haematologica
Cure for thalassemia major – from allogeneic hematopoietic stem cell transplantation to gene therapy | Haematologica

Novel genetic therapeutic approaches for modulating the severity of β‑ thalassemia (Review)
Novel genetic therapeutic approaches for modulating the severity of β‑ thalassemia (Review)

Cureus | Improving Ineffective Erythropoiesis in Thalassemia: A Hope on the  Horizon
Cureus | Improving Ineffective Erythropoiesis in Thalassemia: A Hope on the Horizon

Cure for thalassemia major – from allogeneic hematopoietic stem cell  transplantation to gene therapy | Haematologica
Cure for thalassemia major – from allogeneic hematopoietic stem cell transplantation to gene therapy | Haematologica

Safety and efficacy of thalidomide in patients with transfusion-dependent β- thalassemia: a randomized clinical trial | Signal Transduction and Targeted  Therapy
Safety and efficacy of thalidomide in patients with transfusion-dependent β- thalassemia: a randomized clinical trial | Signal Transduction and Targeted Therapy

Β-Thalassemias | NEJM
Β-Thalassemias | NEJM

Significance of genetic modifiers of hemoglobinopathies leading towards  precision medicine | Scientific Reports
Significance of genetic modifiers of hemoglobinopathies leading towards precision medicine | Scientific Reports

An urgent need for improving thalassemia care due to the wide gap in  current real-life practice and clinical practice guidelines | Scientific  Reports
An urgent need for improving thalassemia care due to the wide gap in current real-life practice and clinical practice guidelines | Scientific Reports

Tricuspid-valve regurgitant jet velocity as a risk factor for death in β- thalassemia | Haematologica
Tricuspid-valve regurgitant jet velocity as a risk factor for death in β- thalassemia | Haematologica

Guidelines for the Management of Transfusion-Dependent Thalassaemia (4th  Edition - Version 2.0) by Thalassaemia International Federation (TIF) -  Issuu
Guidelines for the Management of Transfusion-Dependent Thalassaemia (4th Edition - Version 2.0) by Thalassaemia International Federation (TIF) - Issuu

β-Thalassemia | Genetics in Medicine
β-Thalassemia | Genetics in Medicine

2021 update on clinical trials in β‐thalassemia - Musallam - 2021 -  American Journal of Hematology - Wiley Online Library
2021 update on clinical trials in β‐thalassemia - Musallam - 2021 - American Journal of Hematology - Wiley Online Library

Advances in genome editing: the technology of choice for precise and  efficient β-thalassemia treatment | Gene Therapy
Advances in genome editing: the technology of choice for precise and efficient β-thalassemia treatment | Gene Therapy